Skip to main content

Table 1 Demographics of Patients

From: Relationship between plasma Atherogenic index and final pathology of Bosniak III-IV renal masses: a retrospective, single-center study

Age (year) median (min-max) 61 (33–84)
Gender (n, %) Male 109 (64.5%)
Female (n, %) 60 (35.5%)
Side (n, %) Right (n, %) 84 (49.7%)
Left (n, %) 85 (50.3%)
Body Mass Index (kg/m2) mean ± SD 29.00 ± 4.28
Tumour Size (cm) median (min-max) 6.5 (2–18)
Tumour Localisation (n, %) Lower Pole 26 (15.4%)
Middle Pole 97 (57.4%)
Upper Pole 46 (27.2%)
Tumour Type (n, %) Clear Cell 114 (67.5%)
Chromophobe Cell 16 (9.5%)
Papillary 15 (8.9%)
Angiomyolipoma 11 (6.5%)
Oncocytoma 13 (7.7%)
Malignancy (n, %) Malign 145 (85.8%)
Benign 24 (14.2%)
Fuhrman Grade (n, %) Grade 2 43 (33.3%)
Grade 3 71 (55.0%)
Grade 4 15 (11.6%)
Tumour Stage (n, %) T1a 24 (16.7%)
T1b 36 (25.0%)
T2a 16 (11.1%)
T2b 6 (4.2%)
T3a 46 (31.9%)
T3b 11 (7.6%)
T4 5 (3.5%)
Smoking Status (n, %) Exist 116 (68.6%)
None 53 (31.4%)
Diabetes Mellitus (n, %) Exist 67 (39.6%)
None 102 (60.4%)
Hypertension (n, %) Exist 105 (62.1%)
None 64 (37.9%)
Triglyceride Value [mg/dl] median (min-max) 145 (68–1019)
HDL-Cholesterol Value [mg/dl] mean ± SD 41.12 ± 11.94
Plasma Atherogenic Index Value median (min-max) 0.53 (0.15–1.58)